|
SYNCRIP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.757600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.951800E-01 |
| Normal-vs-Stage2 |
6.243800E-01 |
| Normal-vs-Stage3 |
2.013800E-01 |
| Normal-vs-Stage4 |
5.129200E-01 |
| Stage1-vs-Stage2 |
7.220000E-01 |
| Stage1-vs-Stage3 |
1.886990E-01 |
| Stage1-vs-Stage4 |
5.987600E-01 |
| Stage2-vs-Stage3 |
5.049200E-01 |
| Stage2-vs-Stage4 |
7.915400E-01 |
| Stage3-vs-Stage4 |
7.664000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.974400E-01 |
| Normal-vs-AfricanAmerican |
2.919000E-01 |
| Normal-vs-Asian |
2.007200E-01 |
| Caucasian-vs-AfricanAmerican |
6.828800E-01 |
| Caucasian-vs-Asian |
3.487800E-01 |
| AfricanAmerican-vs-Asian |
2.454000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.686200E-01 |
| Normal-vs-Female |
2.617700E-02 |
| Male-vs-Female |
1.916220E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.111400E-01 |
| Normal-vs-Extreme_Weight |
2.942000E-01 |
| Normal-vs-Obese |
5.896300E-02 |
| Normal-vs-Extreme_Obese |
7.249000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.714800E-01 |
| Normal_Weight-vs-Obese |
1.010420E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.780000E-01 |
| Extreme_Weight-vs-Obese |
8.703100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.983600E-01 |
| Obese-vs-Extreme_Obese |
2.288200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.693800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.888000E-02 |
| Normal-vs-Age(61-80Yrs) |
8.817200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.450200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.838000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.447800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.778100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.816500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.958100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.819200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.448400E-01 |
| Normal-VS-Type2 PRCC |
5.306200E-01 |
| Normal-VS-KIRP CIMP |
1.661580E-01 |
| Normal-VS-Unclassified PRCC |
5.121400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.448200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.527600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.304600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.794000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.933200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.857400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.932000E-02 |
| Normal-vs-N1 |
1.009680E-02 |
| Normal-vs-N2 |
1.140360E-02 |
| N0-vs-N1 |
1.441130E-04 |
| N0-vs-N2 |
3.455200E-01 |
| N1-vs-N2 |
2.878400E-02 |
|
|
